Indications include unique NaturalVue Multifocal lens for myopia progression control
Atlanta, Georgia, USA 31 January 2018: Visioneering Technologies, Inc. (ASX:VTI), an innovative US-based medical device company dedicated to developing advanced products that improve vision, announced today receipt of European CE Mark (Conformité Européenne) for commercialization in the European Union of its portfolio of proprietary NaturalVue® (etafilcon A) brand 1 Day Contact Lenses, including Sphere, Toric, Multifocal and Multifocal Toric. VTI’s CE Mark includes an indication for VTI’s unique NaturalVue Multifocal (NVMF) for myopic progression control (the control of progressive nearsightedness). NVMF contact lenses feature VTI’s innovative Neurofocus Optics® Technology, which employs a patented extended depth-of-focus design to address known optical risk factors associated with myopia progression. The innovative NVMF lens design allows it to be used for both myopic progression control and presbyopia (the age-related loss of ability to see near objects).
For further information please download PDF attached:
Download this document
